Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Trans Care In Court: DOJ Memo, Ohio Ban And Insurer Loss No Photo Available

Gianna Ferrarin

Ohio's highest court is allowing the state to enforce a law banning the use of puberty blockers and hormones for minors seeking to med... (more story)

This Week's Healthcare Earnings: Tariffs Galore No Photo Available

Yeji Jesse Lee

Tariffs were, unsurprisingly, a major theme on investor calls this past week, as around a dozen healthcare companies released their qu... (more story)

Eli Lilly Opens New Front Against Weight-Drug Compounders No Photo Available

Mark Payne

Pharma giant Eli Lilly is taking a new tack in its efforts to protect its lucrative weight-loss drugs by raising allegations that tele... (more story)